NMD Pharma Identifies New Cause of Age-Related Muscle Weakness
NMD Pharma, Aarhus, Denmark, July 23, 2026 NMD Pharma has announced the publication of groundbreaking clinical and preclinical research...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
NMD Pharma, Aarhus, Denmark, July 23, 2026 NMD Pharma has announced the publication of groundbreaking clinical and preclinical research...
AARHUS, Denmark, June 17, 2026 NMD Pharma A/S announced new positive clinical findings from its Phase 2a SYNAPSE-CMT study...
